Cargando…
Ryzyko przeniesienia czynników zakaźnych przez transfuzje w Polsce
Blood transfusion in Poland is the safest in history. High virological level of safety has been achieved mainly by improving not only the qualification of donors and methods used for donor screening, but also applying leukoreduction, pathogen reduction technology and grace period for serum. In this...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Polskie Towarzystwo Hematologów i Transfuzjologów, Instytut Hematologii i Transfuzjologii. Published by Elsevier Sp. z o.o.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094117/ https://www.ncbi.nlm.nih.gov/pubmed/32226060 http://dx.doi.org/10.1016/j.achaem.2017.07.006 |
_version_ | 1783510403869835264 |
---|---|
author | Grabarczyk, Piotr Kopacz, Aneta Sulkowska, Ewa Kalińska, Aleksandra |
author_facet | Grabarczyk, Piotr Kopacz, Aneta Sulkowska, Ewa Kalińska, Aleksandra |
author_sort | Grabarczyk, Piotr |
collection | PubMed |
description | Blood transfusion in Poland is the safest in history. High virological level of safety has been achieved mainly by improving not only the qualification of donors and methods used for donor screening, but also applying leukoreduction, pathogen reduction technology and grace period for serum. In this article, we discuss the improvement of the epidemic situation among blood donors for hepatitis B virus (HBV) and hepatitis C virus (HCV) and the increasing trend for HIV. Preliminary results of residual risk calculation for these pathogens are presented. Hepatitis E virus (HEV) and Babesia microti were considered as new factors potentially relevant for the safety of blood transfusion in our country. Due to evidence of West Nile virus (WNV) circulation in the ecosystem in Poland, it is also necessary to monitor the infections with this pathogen. In this article, it was emphasized that the reporting of all possible complications associated with transfusion and meticulous implementation of the look-back procedure play a key role for monitoring the risk of transmission of infectious agents by blood. It is especially important in view of the increasing epidemiological problems associated with emerging infectious agents. |
format | Online Article Text |
id | pubmed-7094117 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Polskie Towarzystwo Hematologów i Transfuzjologów, Instytut Hematologii i Transfuzjologii. Published by Elsevier Sp. z o.o. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70941172020-03-25 Ryzyko przeniesienia czynników zakaźnych przez transfuzje w Polsce Grabarczyk, Piotr Kopacz, Aneta Sulkowska, Ewa Kalińska, Aleksandra Acta Haematol Pol Praca poglądowa/Review Blood transfusion in Poland is the safest in history. High virological level of safety has been achieved mainly by improving not only the qualification of donors and methods used for donor screening, but also applying leukoreduction, pathogen reduction technology and grace period for serum. In this article, we discuss the improvement of the epidemic situation among blood donors for hepatitis B virus (HBV) and hepatitis C virus (HCV) and the increasing trend for HIV. Preliminary results of residual risk calculation for these pathogens are presented. Hepatitis E virus (HEV) and Babesia microti were considered as new factors potentially relevant for the safety of blood transfusion in our country. Due to evidence of West Nile virus (WNV) circulation in the ecosystem in Poland, it is also necessary to monitor the infections with this pathogen. In this article, it was emphasized that the reporting of all possible complications associated with transfusion and meticulous implementation of the look-back procedure play a key role for monitoring the risk of transmission of infectious agents by blood. It is especially important in view of the increasing epidemiological problems associated with emerging infectious agents. Polskie Towarzystwo Hematologów i Transfuzjologów, Instytut Hematologii i Transfuzjologii. Published by Elsevier Sp. z o.o. 2017 2017-07-24 /pmc/articles/PMC7094117/ /pubmed/32226060 http://dx.doi.org/10.1016/j.achaem.2017.07.006 Text en © 2017 Polskie Towarzystwo Hematologów i Transfuzjologów, Instytut Hematologii i Transfuzjologii. Published by Elsevier Sp. z o.o. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Praca poglądowa/Review Grabarczyk, Piotr Kopacz, Aneta Sulkowska, Ewa Kalińska, Aleksandra Ryzyko przeniesienia czynników zakaźnych przez transfuzje w Polsce |
title | Ryzyko przeniesienia czynników zakaźnych przez transfuzje w Polsce |
title_full | Ryzyko przeniesienia czynników zakaźnych przez transfuzje w Polsce |
title_fullStr | Ryzyko przeniesienia czynników zakaźnych przez transfuzje w Polsce |
title_full_unstemmed | Ryzyko przeniesienia czynników zakaźnych przez transfuzje w Polsce |
title_short | Ryzyko przeniesienia czynników zakaźnych przez transfuzje w Polsce |
title_sort | ryzyko przeniesienia czynników zakaźnych przez transfuzje w polsce |
topic | Praca poglądowa/Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094117/ https://www.ncbi.nlm.nih.gov/pubmed/32226060 http://dx.doi.org/10.1016/j.achaem.2017.07.006 |
work_keys_str_mv | AT grabarczykpiotr ryzykoprzeniesieniaczynnikowzakaznychprzeztransfuzjewpolsce AT kopaczaneta ryzykoprzeniesieniaczynnikowzakaznychprzeztransfuzjewpolsce AT sulkowskaewa ryzykoprzeniesieniaczynnikowzakaznychprzeztransfuzjewpolsce AT kalinskaaleksandra ryzykoprzeniesieniaczynnikowzakaznychprzeztransfuzjewpolsce |